Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Craig, Andrew P ^a   Kong, Fabian ^b   Yeruva, Laxmi ^c   Hocking, Jane S ^b   Rank, Roger G ^c   Wilson, David P ^a   Donovan, Basil ^a,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d SYDNEY EYE HOSPITAL   (Australia)

Author keywords

Azithromycin; Chlamydia; Doxycycline; Re infection

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; ANTIINFECTIVE AGENT;

ARTICLE; CHLAMYDIASIS; DRUG EFFICACY; DRUG SUBSTITUTION; FEMALE; GASTROINTESTINAL INFECTION; GENITAL TRACT INFECTION; HUMAN; INOCULATION; MATHEMATICAL MODEL; META ANALYSIS; PREVALENCE; PROBABILITY; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DRUG EFFECTS; GASTROINTESTINAL TRACT; GENITAL DISEASES, FEMALE; THEORETICAL MODEL; TREATMENT OUTCOME; UROGENITAL SYSTEM;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DOXYCYCLINE; FEMALE; GASTROINTESTINAL TRACT; GENITAL DISEASES, FEMALE; HUMANS; MODELS, THEORETICAL; TREATMENT OUTCOME; UROGENITAL SYSTEM;

EID: 84928745683     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-0939-3     Document Type: Article

References (17)

1. Handsfield HH. Questioning azithromycin for chlamydial infection. Sex Transm Dis. 2011;38(11):1028-9.
2. Lau C-Y, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002;29(9):497-502.
3. Kong FYS, Tabrizi SN, Law M, Vodstrcil LA, Chen M, Fairley CK, et al. Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials. Clin Infect Dis. 2014;59(2):193-205. doi:10.1093/cid/ciu220.
4. Kong FYS, Tabrizi SN, Fairley CK, Vodstrcil LA, Huston WM, Chen M, et al. The Efficacy of Azithromycin and Doxycycline for the Treatment of Rectal Chlamydia Infection - a Systematic Review and Meta-analysis. J Antimicrob Chemother. 2015;70(5):1290-7. doi:10.1093/jac/dku574.
5. Hocking JS, Kong FY, Timms P, Huston WM, Tabrizi SN. Treatment of rectal chlamydia infection may be more complicated than we originally thought. J Antimicrob Chemother. 2014;70(4):961-4. doi:10.1093/jac/dku493.
6. Dukers-Muijrers NH, van Liere GA, Wolffs PF, Heijer CD, Werner MI, Hoebe CJ. Antibiotic use before chlamydia and gonorrhea genital and extragenital screening in the STI clinic setting. Antimicrob Agents Chemother. 2014;59(1):121-8. doi:10.1128/aac.03932-14.
7. Yeruva L, Spencer N, Bowlin AK, Wang Y, Rank RG. Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection. Pathoge Dis. 2013;68(3):88-95. doi:10.1111/2049-632x.12052.
8. Rank RG, Yeruva L. "Hidden in plain sight:" Chlamydial gastrointestinal infection and its relevance to "persistence" in human genital infections. Infect Immun. 2014;82(4):1362-71. doi:10.1128/iai.01244-13.
9. Yeruva L, Melnyk S, Spencer N, Bowlin A, Rank RG. Differential susceptibilities to azithromycin treatment of chlamydial infection in the gastrointestinal tract and cervix. Antimicrob Agents Chemother. 2013;57(12):6290-4. doi:10.1128/aac.01405-13.
10. Perry LL, Hughes S. Chlamydial colonization of multiple mucosae following infection by any mucosal route. Infect Immun. 1999;67(7):3686-9.
11. Schachter J, Grossman M, Sweet RL, Holt J, Jordan C, Bishop E. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA. 1986;255(24):3374-7. doi:10.1001/jama.1986.03370240044034.
12. Scott LaMontagne D, Baster K, Emmett L, Nichols T, Randall S, McLean L, et al. Incidence and reinfection rates of genital chlamydial infection among women aged 16-24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group. Sex Transm Infect. 2007;83(4):292-303. doi:10.1136/sti.2006.022053.
13. Workowski KA, Lampe MF, Wong KG, Watts MB, Stamm WE. Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy: evidence against persistent infection. JAMA. 1993;270(17):2071-5.
14. Ding A, Challenor R. Rectal Chlamydia in heterosexual women: more questions than answers. Int J STD AIDS. 2014;25(8):587-92.
15. van Liere GA, Hoebe CJ, Wolffs PF, Dukers-Muijrers NH. High co-occurrence of anorectal chlamydia with urogenital chlamydia in women visiting an STI clinic revealed by routine universal testing in an observational study; a recommendation towards a better anorectal chlamydia control in women. BMC Infect Dis. 2014;14(1):274. doi:10.1186/1471-2334-14-274.
16. Gratrix J, Singh AE, Bergman J, Egan C, Plitt SS, McGinnis J, et al. Evidence for Increased Chlamydia Case Finding After the Introduction of Rectal Screening Among Females Attending Two Canadian STI Clinics. Clin Infect Dis. 2014;60(3):398-404. doi: 10.1093/cid/ciu831.
17. Bachmann LH, Stephens J, Richey CM, Hook EWI. Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance. Sex Transm Dis. 1999;26(5):272-8.